Epidemiology Practice Questions

Q: What is the clinical incubation period of Filariasis?

8 to 16 months. ### Explanation The **clinical incubation period** of Filariasis (specifically Lymphatic Filariasis caused by *Wuchereria bancrofti*) refers to the time interval between the entry of infective larvae ($L_3$) via a mosquito bite and the manifestation of clinical symptoms. **1. Why Option C is Correct:** In Filariasis, the clinical incubation period is typically **8 to 16 months**. This prolonged duration is due to the slow maturation of the larvae into adult worms within the lymphatic system. Clinical symptoms, such as lymphangitis and retrograde fever, only appear once the adult worms begin to cause inflammatory and obstructive changes in the lymphatics. **2. Analysis of Incorrect Options:** * **Option A (10 to 20 days):** This is far too short for Filariasis. This timeframe is more characteristic of the **Pre-patent period** (the time between infection and the appearance of microfilariae in the blood), which is actually about 6–12 months, or the extrinsic incubation period in the mosquito (10–14 days). * **Option B & D (3 to 6 months / 6 to 12 months):** While these represent the time required for larvae to reach the adult stage, they generally precede the onset of overt clinical disease. Clinical symptoms usually lag behind the biological maturation of the parasite. **3. NEET-PG High-Yield Pearls:** * **Extrinsic Incubation Period:** 10 to 14 days (occurs within the *Culex* mosquito). * **Pre-patent Period:** 6 to 12 months (time until microfilariae are detectable in peripheral blood). * **Biological Vector:** *Culex quinquefasciatus* is the most common vector in India. * **Drug of Choice:** Diethylcarbamazine (DEC) 6 mg/kg for 12 days. * **Mass Drug Administration (MDA):** Annual single dose of DEC + Albendazole (or Ivermectin in specific areas).

Q: Which of the following is NOT a characteristic of a health indicator?

Affordability. **Explanation:** Health indicators are variables used to measure the health status of a community or the effectiveness of health systems. According to standard epidemiological criteria (often cited by WHO), a "good" health indicator must possess specific scientific qualities. **Why "Affordability" is the correct answer:** While budget is a practical concern in public health administration, **Affordability** is not a formal scientific characteristic of a health indicator. The standard criteria focus on the technical robustness and utility of the data rather than the cost of the intervention or the measurement itself. **Analysis of Incorrect Options:** * **Validity:** This refers to the ability of an indicator to measure what it is intended to measure (accuracy). An indicator must reflect the true situation it represents. * **Reliability:** Also known as reproducibility, this ensures that the indicator yields the same results if measured by different people at different times under similar circumstances. * **Feasibility:** This means that the data required for the indicator should be capable of being collected and analyzed using available resources and technical expertise. **High-Yield Clinical Pearls for NEET-PG:** * **Characteristics of an Indicator (V-R-S-S-F):** Remember the mnemonic for the five key properties: **V**alidity, **R**eliability, **S**ensitivity (picks up small changes), **S**pecificity (reflects changes only in the situation concerned), and **F**easibility. * **Objective vs. Subjective:** Indicators can be objective (e.g., Mortality rates) or subjective (e.g., Quality of Life scales). * **Commonly Asked:** The **Infant Mortality Rate (IMR)** is considered one of the most sensitive indicators of the overall health status and socio-economic development of a country.

Q: If the population growth rate is 1.2-1.5%, in how many years will the population double?

47-58 years. ### Explanation **1. Understanding the Correct Answer (Option D)** The time required for a population to double is calculated using the **Rule of 70**. This is a mathematical formula used in demography and epidemiology to estimate the doubling time based on a constant annual growth rate. The formula is: **Doubling Time (T) = 70 / Annual Growth Rate (r)** * **At 1.2% growth rate:** $70 \div 1.2 \approx 58.3$ years. * **At 1.5% growth rate:** $70 \div 1.5 \approx 46.6$ years. Therefore, at a growth rate of 1.2–1.5%, the population will double in approximately **47–58 years**. **2. Analysis of Incorrect Options** * **Option A (23-28 years):** This would require a very high growth rate of approximately 2.5–3.0% ($70 \div 3 = 23.3$). * **Option B (28-35 years):** This corresponds to a growth rate of 2.0–2.5% ($70 \div 2 = 35$). * **Option C (35-47 years):** This corresponds to a growth rate of 1.5–2.0%. While 1.5% is the upper limit of the question, the range does not account for the 1.2% lower limit. **3. High-Yield Pearls for NEET-PG** * **Rule of 70 vs. Rule of 69:** While the Rule of 70 is standard for exams, some texts use 69 for more precise continuous compounding; however, 70 is the preferred "easy-math" constant for NEET-PG. * **Demographic Transition:** India is currently in **Stage 3** (Late Expanding) of the demographic transition, characterized by a falling birth rate and a rapidly declining death rate. * **Vital Statistics:** Always keep updated with the latest **SRS (Sample Registration System)** data. As of recent trends, India's annual exponential growth rate has been declining (currently approx. 1.0–1.1%). * **Net Reproduction Rate (NRR):** The goal of the National Health Policy is to achieve **NRR = 1** (Replacement level fertility), which corresponds to a Total Fertility Rate (TFR) of 2.1.

Q: What is the most common cause of death in developed countries?

Ischemic heart disease. **Explanation:** **Correct Answer: A. Ischemic Heart Disease (IHD)** In developed countries, the epidemiological transition has shifted the burden of disease from communicable to non-communicable diseases (NCDs). Ischemic Heart Disease (also known as Coronary Artery Disease) is currently the leading cause of mortality globally and specifically in developed nations. This is attributed to increased life expectancy, sedentary lifestyles, and high prevalence of metabolic risk factors such as hypertension, hyperlipidemia, and obesity. According to the WHO Global Health Estimates, IHD remains the "World’s Biggest Killer," accounting for approximately 16% of total deaths worldwide. **Analysis of Incorrect Options:** * **B. Accidents:** While road traffic accidents (RTAs) and unintentional injuries are a significant cause of death among the younger population (ages 15–29), they do not surpass the total mortality rate of cardiovascular diseases in the general population of developed countries. * **C. Infectious disease:** These were the leading cause of death historically. However, due to advancements in sanitation, immunization, and antibiotics, infectious diseases now account for a much smaller fraction of mortality in developed nations compared to developing or low-income countries. **High-Yield Clinical Pearls for NEET-PG:** * **Global Burden:** IHD is the #1 cause of death worldwide. * **Developing Countries:** While infectious diseases are still prevalent, NCDs (led by IHD) are rapidly becoming the leading cause of death here as well (Double Burden of Disease). * **Most Common Cancer Death:** Globally, Lung Cancer is the leading cause of cancer-related mortality in both developed and developing regions. * **Leading Disability-Adjusted Life Years (DALYs):** IHD is also a top contributor to the global DALYs.

Q: In the natural history of disease, all are true about the period of pathogenesis, EXCEPT:

Screening does not affect the course of the phase. In the natural history of disease, the **Pathogenesis Phase** begins the moment the disease agent enters a susceptible human host. ### Why Option C is the Correct Answer (The Exception) Screening is a core component of **Secondary Prevention**. Its primary objective is the early detection of disease during the sub-clinical or early symptomatic stage of the pathogenesis phase. By identifying the disease early, medical intervention can halt the progression, prevent complications, and significantly alter the clinical course. Therefore, stating that screening "does not affect the course" is factually incorrect. ### Analysis of Other Options * **A. Occurs after the agent enters the host body:** This is the definition of pathogenesis. It contrasts with the *Pre-pathogenesis phase*, where the agent, host, and environment exist but have not yet interacted within the human body. * **B. Tertiary prevention is possible at this stage:** Tertiary prevention (disability limitation and rehabilitation) occurs during the late stages of pathogenesis to reduce the impact of long-term disease or permanent impairment. * **C. A sub-clinical phase can be present:** Pathogenesis is divided into the **pre-symptomatic (sub-clinical)** phase, where physiological changes occur without visible symptoms, and the **clinical phase**, where signs and symptoms appear. ### NEET-PG High-Yield Pearls * **Pre-pathogenesis:** Corresponds to **Primary Prevention** (Health promotion and Specific protection). * **Pathogenesis:** Corresponds to **Secondary Prevention** (Early diagnosis and Treatment) and **Tertiary Prevention**. * **Biological Onset:** The exact point where pathogenesis begins; often occurs long before the "Clinical Horizon" (the point where symptoms become manifest). * **Screening:** Aims to shift the diagnosis to the left of the clinical horizon.

Q: What is the analysis of routine measurements aimed at detecting changes in the environment known as?

Monitoring. **Explanation:** **Why Monitoring is Correct:** Monitoring refers to the **performance and analysis of routine measurements** aimed at detecting changes in the environment or health status of a population. It is a continuous process that measures the performance of an activity to ensure it is proceeding according to plan. In environmental health, this involves tracking levels of pollutants (e.g., air quality index or water chlorine levels) to ensure they remain within safe limits. **Analysis of Incorrect Options:** * **Surveillance:** While often confused with monitoring, surveillance is the continuous **scrutiny** of all aspects of occurrence and spread of a disease that are pertinent to effective control. It is broader and involves data collection, analysis, and **action** (e.g., Integrated Disease Surveillance Programme). * **Isolation:** This is a clinical intervention where an infected individual is separated from others during the period of communicability to prevent the direct or indirect transmission of the infectious agent. * **Randomized Controlled Trial (RCT):** This is an analytical epidemiological study design used to test the efficacy of a new drug or intervention. It is not a routine measurement of the environment. **High-Yield Clinical Pearls for NEET-PG:** * **Monitoring vs. Surveillance:** Monitoring is a sub-component of surveillance. Monitoring tracks the *process*, while surveillance tracks the *outcome* and involves a feedback loop for action. * **Sentinel Surveillance:** A method used when notification data is silent; it identifies "missing cases" to estimate the total health problem in a community. * **Key Distinction:** If the question mentions "routine measurements" or "performance of an activity," think **Monitoring**. If it mentions "continuous scrutiny" or "distribution of disease," think **Surveillance**.

Q: A primary health center (PHC) typically manages 40-50 cases of a specific condition in a week. This week, the PHC has recorded 48 cases, which is in line with previous records. What is this pattern of disease occurrence called?

Endemic. ### Explanation **Why Endemic is Correct:** The term **Endemic** refers to the constant presence of a disease or infectious agent within a given geographic area or population group. It represents the "usual" or "expected" prevalence of a disease. In this scenario, the PHC typically manages 40-50 cases weekly. Since the current count of 48 cases falls squarely within this expected range, it signifies the **baseline level** of the disease in that community. **Analysis of Incorrect Options:** * **Epidemic:** This is defined as the occurrence of cases of an illness clearly in **excess of normal expectancy**. If the PHC had suddenly reported 150 cases instead of the usual 40-50, it would be classified as an epidemic. * **Sporadic:** This refers to cases that occur **irregularly, haphazardly, or infrequently** from time to time and are generally scattered (e.g., Tetanus, Polio in some regions). The scenario describes a consistent, predictable pattern, which contradicts the definition of sporadic. * **Outbreak:** This term is often used interchangeably with an epidemic but usually refers to a **localized** increase in cases (e.g., in a village, hostel, or camp) over a short period. **High-Yield Clinical Pearls for NEET-PG:** * **Hyperendemic:** A disease that is constantly present at a high level and affects all age groups equally. * **Holoendemic:** A disease that affects children early in life, reaching an equilibrium such that the adult population shows much lower evidence of the disease (e.g., Malaria in some African regions). * **Epizootic:** An epidemic occurring in an animal population (e.g., Anthrax, Rabies). * **Enzootic:** An endemic disease among animals. * **Key Distinction:** The threshold for an "Epidemic" is not a fixed number; it is always relative to the "usual" experience of that specific population. Even **one case** of a disease long absent (like Polio in a certified free zone) can be considered an epidemic.

Q: Prevalence is a:

Proportion. **Explanation:** **Why Proportion is the Correct Answer:** In epidemiology, **Prevalence** measures the total number of existing cases (old and new) in a specific population at a given point or period in time. It is mathematically expressed as: $$\text{Prevalence} = \frac{\text{Number of existing cases of a disease}}{\text{Total population at risk at that time}}$$ Because the **numerator (cases) is a part of the denominator (total population)**, it is by definition a **Proportion**. It is usually expressed as a decimal or a percentage (e.g., 0.05 or 5%), but its fundamental mathematical nature is a proportion. **Why Other Options are Incorrect:** * **Rate:** A rate measures the speed of occurrence of an event over time (e.g., Incidence Rate). It must have a **time dimension** in the denominator (e.g., per 1,000 person-years). Prevalence is a "snapshot" and lacks this time element. * **Ratio:** A ratio expresses the relation between two independent quantities where the numerator is *not* part of the denominator (e.g., Sex Ratio, Waist-Hip Ratio). * **Percentage:** While prevalence is often *reported* as a percentage, "Proportion" is the more accurate mathematical classification. A percentage is simply a proportion multiplied by 100. **High-Yield Clinical Pearls for NEET-PG:** * **Incidence is a Rate:** It measures only *new* cases. * **Prevalence = Incidence × Mean Duration of disease ($P = I \times D$).** This formula is valid only when the disease is stable (stationary population). * **Factors increasing Prevalence:** Longer duration of illness, prolongation of life without a cure, increase in new cases (incidence), and in-migration of cases. * **Factors decreasing Prevalence:** Shorter duration of disease, high case fatality rate, and improved cure rates.

Question 1

What is the clinical incubation period of Filariasis?

Accepted Answer

8 to 16 months

Answer

10 to 20 days

Answer

3 to 6 months

Answer

6 to 12 months

Question 2

Which of the following is NOT a characteristic of a health indicator?

Accepted Answer

Affordability

Answer

Validity

Answer

Reliability

Answer

Feasibility

Question 3

If the population growth rate is 1.2-1.5%, in how many years will the population double?

Accepted Answer

47-58 years

Answer

23-28 years

Answer

28-35 years

Answer

35-47 years

Question 4

General fertility rate is a better measure of fertility than the crude birth rate because the denominator includes which of the following?

Accepted Answer

Females aged 15-45 years

Answer

The midyear population

Answer

The total female population

Answer

The married female population

Question 5

What is the most common cause of death in developed countries?

Accepted Answer

Ischemic heart disease

Answer

Accidents

Answer

Infectious disease

Answer

None of the above

Question 6

In the natural history of disease, all are true about the period of pathogenesis, EXCEPT:

Accepted Answer

Screening does not affect the course of the phase

Answer

Occurs after the agent enters the host body

Answer

Tertiary prevention is possible at this stage

Answer

A sub-clinical phase can be present

Question 7

What is the most significant indicator of fertility?

Accepted Answer

Net reproductive rate

Answer

Family size

Answer

Gross reproduction rate

Answer

General fertility rate

Question 8

What is the analysis of routine measurements aimed at detecting changes in the environment known as?

Accepted Answer

Monitoring

Answer

Surveillance

Answer

Isolation

Answer

Randomized Controlled Trial

Question 9

A primary health center (PHC) typically manages 40-50 cases of a specific condition in a week. This week, the PHC has recorded 48 cases, which is in line with previous records. What is this pattern of disease occurrence called?

Accepted Answer

Endemic

Answer

Epidemic

Answer

Sporadic

Answer

Outbreak

Question 10

Prevalence is a:

Accepted Answer

Proportion

Answer

Rate

Answer

Ratio

Answer

Percentage

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?